Trevi Therapeutics
Clinical trials sponsored by Trevi Therapeutics, explained in plain language.
-
Early trial tests new tablet to help IPF patients breathe
Symptom relief Recruiting nowThis is an early safety study for people with idiopathic pulmonary fibrosis (IPF). Researchers want to see if taking increasing doses of a long-acting tablet called nalbuphine ER is safe and if it affects breathing. The study will involve about 10 participants and will closely mo…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Scientists test if a big meal changes how your body absorbs a pain drug
Knowledge-focused Recruiting nowThis early-stage study aims to understand if eating a high-fat, high-calorie meal changes how the body absorbs a long-acting version of the pain medication nalbuphine. It will involve 60 healthy volunteers who will take the drug once with food and once without, in a random order.…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC